Taurultam - CISMeF

Preferred Label : Taurultam;

NCIt definition : A reversible metabolite of taurolidine and an amino acid taurine derivative, with antibacterial and antineoplastic activity. Taurultam, like its congener taurolidine, inhibits proliferation of microvascular endothelial cells, although to a lesser extent, by selectively inhibiting the adhesion of endothelial cells to laminin but not to collagen I and fibronectin.;

UNII : LIX7OM008P;

InChIKey : RJGYJMFQWGPBGM-UHFFFAOYSA-N;

CAS number : 38668-01-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 38668-01-8 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Chemical formula : C3H8N2O2S;

PubMed : 17395893; 9552463;

Details

Origin ID

C75290;

UMLS CUI

C0673101;

Currated CISMeF NLP mapping
- taurultam [MeSH concept]
- taurultam [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- taurultam [MeSH Supplementary Concept]
- taurultam [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients